GHANEM SHARABI

Allopathic & Osteopathic Physicians|Internal Medicine WARREN, MI NPI 1508874504

General Payments — all program years on this page

$4,519.04

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 270
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $736.00 across 40 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $736.0040

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $738.9845
2019 $377.7723
2020 $418.1228
2021 $805.0154
2022 $743.2349
2023 $699.9331
2024 $736.0040

Records — PY2024 (40)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078894903 Actelion Pharmaceuticals US, Inc. $16.10 08/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078894911 Actelion Pharmaceuticals US, Inc. $36.01 08/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096571122 Novo Nordisk Inc $18.04 01/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096672821 Novo Nordisk Inc $1.91 07/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096716546 Novo Nordisk Inc $7.75 04/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096855450 Novo Nordisk Inc $4.89 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097011688 Novo Nordisk Inc $19.60 06/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097247077 Novo Nordisk Inc $20.50 02/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097348385 Novo Nordisk Inc $15.35 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097383345 Novo Nordisk Inc $16.58 11/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097385542 Novo Nordisk Inc $19.69 06/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097385916 Novo Nordisk Inc $17.31 05/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101527488 E.R. Squibb & Sons, L.L.C. $14.62 09/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104250495 AstraZeneca Pharmaceuticals LP $17.12 12/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105391655 AstraZeneca Pharmaceuticals LP $13.73 08/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105694620 AstraZeneca Pharmaceuticals LP $19.77 02/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106073640 ABBVIE INC. $24.91 09/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106073642 ABBVIE INC. $25.42 10/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111704622 Amgen Inc. $16.17 08/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117380508 Amgen Inc. $18.18 01/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117380510 Amgen Inc. $16.69 04/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117380512 Amgen Inc. $14.24 06/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117380514 Amgen Inc. $13.66 07/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117380516 Amgen Inc. $17.53 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118038994 Boehringer Ingelheim Pharmaceuticals, Inc. $17.05 08/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118038996 Boehringer Ingelheim Pharmaceuticals, Inc. $18.83 11/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118038998 Boehringer Ingelheim Pharmaceuticals, Inc. $18.85 06/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118039000 Boehringer Ingelheim Pharmaceuticals, Inc. $20.84 10/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118980524 Otsuka America Pharmaceutical, Inc. $16.90 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131363760 PFIZER INC. $19.12 05/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1134978098 Lilly USA, LLC $16.58 05/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139661934 SANOFI-AVENTIS U.S. LLC $21.08 11/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140164503 Inari Medical, Inc. $15.61 06/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144595518 Xeris Pharmaceuticals, Inc. $16.31 07/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147308841 Mylan Specialty L.P. $24.24 01/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147336285 Mylan Specialty L.P. $16.38 03/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148109603 Inspire Medical Systems, Inc. $33.16 09/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153288943 Ultragenyx Pharmaceutical Inc. $24.46 06/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153301687 Dexcom, Inc. $33.29 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153457285 Salix Pharmaceuticals, a division of Bausch Health US, LLC $17.53 08/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.